High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis (Q28237152)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article (publication date: September 2011)

Language	Label	Description	Also known as
English	High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis	scientific article (publication date: September 2011)

Statements

scholarly article

0 references

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis (English)

0 references

ascending cholangitis

0 references

0 references

ulcerative colitis

1 reference

based on heuristic

inferred from title

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

primary sclerosing cholangitis

1 reference

based on heuristic

inferred from title

Kris V. Kowdley

5

object named as

Kris V Kowdley

0 references

Emmanouil Sinakos

4

object named as

Emmanouil Sinakos

0 references

author name string

John E Eaton

1

0 references

Marina G Silveira

2

0 references

Darrell S Pardi

3

0 references

Velimir A C Luketic

6

0 references

M Edwyn Harrison

7

0 references

Timothy McCashland

8

0 references

Alex S Befeler

9

0 references

Denise Harnois

10

0 references

Roberta Jorgensen

11

0 references

Jan Petz

12

0 references

Keith D Lindor

13

0 references

language of work or name

0 references

publication date

September 2011

0 references

The American Journal of Gastroenterology

0 references

106

0 references

9

0 references

1638-45

0 references

Bile acids as endogenous etiologic agents in gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

20 March 2017

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

20 March 2017

Conversion of 7-ketolithocholic acid to ursodeoxycholic acid by human intestinal anaerobic microorganisms: Interchangeability of chenodeoxycholic acid and ursodeoxycholic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

20 March 2017

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Bile acids as carcinogens in human gastrointestinal cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Cancer risk in patients with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Role of bile acids in colorectal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

2 June 2018

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

2 June 2018

Diagnosis and management of primary sclerosing cholangitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Effects of diet on the fecal excretion and bacterial modification of acidic and neutral steroids, and implications for colon carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fate of low grade dysplasia in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of ursodeoxycholic acid in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirements for induction of DNA strand breaks by lithocholic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2011.156

0 references

release_zin4w4w2bzbu5gpx2qjiya75wm

1 reference

https://api.fatcat.wiki/v0/release/zin4w4w2bzbu5gpx2qjiya75wm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28237152&oldid=1879136492"